Home/Filings/4/0001213900-23-007992
4//SEC Filing

MARTELL RON 4

Accession 0001213900-23-007992

CIK 0001788028other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 4:13 PM ET

Size

5.6 KB

Accession

0001213900-23-007992

Insider Transaction Report

Form 4
Period: 2023-02-02
MARTELL RON
DirectorPresident, CEO and Director
Transactions
  • Award

    Stock Option (right to buy)

    2023-02-02+1,093,8311,093,831 total
    Exercise: $1.78Exp: 2033-02-02Voting Common Stock (1,093,831 underlying)
Footnotes (1)
  • [F1]1/4th of the shares subject to the option shall vest on February 2, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Documents

1 file

Issuer

Jasper Therapeutics, Inc.

CIK 0001788028

Entity typeother

Related Parties

1
  • filerCIK 0001177079

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:13 PM ET
Size
5.6 KB